Netherlands Cancer Institute With Support From Lawmakers, WGS Becoming More Accessible to Netherlands' Cancer Patients Premium Based on results from a pilot study, Dutch lawmakers are advancing a proposal to make WGS a standard test for advanced cancer patients. Breast Cancer Polygenic Risk Score Can Help Predict Risk of Contralateral Disease Based on the study results, the score could be combined with other risk factors to improve predictions of contralateral breast cancer and stratify patients. Metastatic Cancer Treatment Markers Identified in Clinical WGS Study Interim results from a study in the Netherlands suggest whole-genome sequencing can be done fast enough to uncover treatment targets in metastatic cancer patients. Prostate Cancer Metastasis Linked to Development-Related Epigenetic Shift Transcription factor reprogramming during prostate cancer metastases appears to involve epigenetic changes that resemble those at play during prostate development, new research finds. Netherlands Drug Repurposing, Tumor Profiling Trial Results Reported at ESMO The early-stage genomics-based trials suggest tumor sequence can be informative for late-stage cancers, as an ESMO group seeks clinically meaningful translation. Jul 24, 2019 Dutch Startup Gen-X Offers Functional Genome Annotation Services Premium Jan 15, 2018 Desktop Genetics Licenses Genome Editing Assessment Tech Feb 10, 2017 Cancer Research UK Unveils First Winners of Grand Challenge Competition Jul 14, 2016 Immune Gene Mutations Found in Immunotherapy-Resistant Metastatic Melanoma Patients May 10, 2016 'Immunogram' Could Better Personalize Cancer Immunotherapy, Researchers Say Premium Aug 3, 2012 Dutch Researchers Head SU2C Tumor Profiling Study Mar 9, 2012 Netherlands Provides $18M for New Proteomics Facility Oct 31, 2011 EU Funds Breast Cancer Profiling Consortium Jun 15, 2011 Agendia to Collaborate with MD Anderson, Netherlands Institute to Further Validate ColoPrint Premium Jun 9, 2011 Agendia, MD Anderson, Netherlands Cancer Institute Partner on Colorectal Cancer Research May 10, 2011 Agendia, AstraZeneca, NKI Partner to ID Colorectal Cancer Subtypes Breaking News FDA Grants EUAs for SARS-CoV-2 Tests From Thermo Fisher, Phase Scientific Myriad Genetics More Than Doubles Quarterly Revenues Pacific Biosciences Acquires Sample Preparation Firm Circulomics Bruker Posts 34 Percent Jump in Q2 Revenues GenomeWeb Index Gains Slightly in July as Fluidigm, PerkinElmer, Bio-Rad Post Strong Increases Feinstein Institutes for Medical Research Wins $2.9M NIH Grant to Study Polygenic Embryo Screening The Scan And Back The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database. Lacks Family Hires Attorney A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports. For the Unknown The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona. PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.